An Oakland man who allegedly sold $500 worth of fentanyl to an informant working with Maine Drug Enforcement Agency was arrested Wednesday on a charge of aggravated trafficking in schedule W drugs.
Brian Ouellette, 52, allegedly sold 5.8 grams of the synthetic opioid to the informant, who purchased the drugs using money provided by the agency, according to court documents.
An affidavit filed by Jordan Brooks, a special agent with MDEA, states the informant called agents and said they could buy a “half stick of down” from Ouellette. The affidavit states “down” is a street term to describe heroin or fentanyl and “stick” refers to a 10-gram portion, which is approximately the size of a thumb.
The informant called Ouellette who told them to come to the garage of a Smithfield Road home. An undercover MDEA agent drove the informant to the site and parked in the driveway of the home as the informant went into the garage. The informant returned a short time later with a tin foil package containing what the affidavit states tested positive for fentanyl.
The trafficking charge is a Class A felony, punishable by up to 30 years in prison.
The alleged crime was elevated to “aggravated” trafficking because Ouellette had been previously convicted of unlawful trafficking in scheduled drugs in 2014.
Ouellette was taken to Kennebec County jail with bail set, initially, at $15,000.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less